Aptorum Group Ltd
APM1.170USD
+0.050+4.46%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
8.36MMarket Cap
LossP/E TTM
More Details of Aptorum Group Ltd Company
Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.
Aptorum Group Ltd Info
Ticker SymbolAPM
Company nameAptorum Group Ltd
IPO dateDec 18, 2018
CEOHuen (Ian)
Number of employees1
Security typeOrdinary Share
Fiscal year-endDec 18
Address17 Hanover Square
CityLONDON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeW1S 1BN
Phone85239537700
Websitehttps://www.aptorumgroup.com/
Ticker SymbolAPM
IPO dateDec 18, 2018
CEOHuen (Ian)
Company Executives of Aptorum Group Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Ian Huen
Mr. Ian Huen
Chief Executive Officer, Founder, Executive Director
Chief Executive Officer, Founder, Executive Director
137.66K
--
Mr. K.K. Wong ,
Mr. K.K. Wong ,
Head of Finance
Head of Finance
--
--
Prof. Douglas W. Arner
Prof. Douglas W. Arner
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. Justin Wu
Dr. Justin Wu
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ian Huen
Mr. Ian Huen
Chief Executive Officer, Founder, Executive Director
Chief Executive Officer, Founder, Executive Director
137.66K
--
Mr. K.K. Wong ,
Mr. K.K. Wong ,
Head of Finance
Head of Finance
--
--
Prof. Douglas W. Arner
Prof. Douglas W. Arner
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Dr. Justin Wu
Dr. Justin Wu
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, May 24
Updated: Sat, May 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
CGY Investments Ltd
8.41%
Jurchen Investment Corp
5.83%
Huen (Ian)
2.17%
Osaic Holdings, Inc.
0.09%
Other
83.50%
Shareholders
Shareholders
Proportion
CGY Investments Ltd
8.41%
Jurchen Investment Corp
5.83%
Huen (Ian)
2.17%
Osaic Holdings, Inc.
0.09%
Other
83.50%
Shareholder Types
Shareholders
Proportion
Corporation
14.24%
Individual Investor
2.17%
Investment Advisor
0.09%
Other
83.50%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
12
5.79K
2.02%
--
2025Q3
13
5.79K
2.40%
-38.17K
2025Q2
14
43.95K
2.38%
-50.34K
2025Q1
15
94.29K
1.51%
+13.79K
2024Q4
14
47.75K
2.58%
-7.87K
2024Q3
17
55.62K
3.26%
-20.18K
2024Q2
17
75.81K
2.36%
+17.53K
2024Q1
19
58.28K
2.72%
-21.61K
2023Q4
20
43.80K
2.78%
+551.00
2023Q3
20
43.25K
4.26%
-3.04K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
CGY Investments Ltd
533.58K
14%
--
--
Dec 31, 2024
Jurchen Investment Corp
370.31K
9.71%
--
--
Dec 31, 2024
Huen (Ian)
137.66K
3.61%
+137.66K
--
Dec 31, 2024
Osaic Holdings, Inc.
5.50K
0.1%
--
--
Jun 30, 2025
Citi Investment Research (US)
995.00
0.02%
+976.00
+5136.84%
Jun 30, 2025
SBI Securities Co., Ltd.
7.00
0%
-60.00
-89.55%
Jun 30, 2025
Geode Capital Management, L.L.C.
37.45K
0.7%
+502.00
+1.36%
Jun 30, 2025
XTX Markets LLC
--
0%
-10.04K
-100.00%
Jun 30, 2025
Morgan Stanley & Co. LLC
--
0%
-21.16K
-100.00%
Jun 30, 2025
UBS Financial Services, Inc.
--
0%
-3.35K
-100.00%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Fidelity Nasdaq Composite Index ETF
0%
Fidelity Nasdaq Composite Index ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 20, 2023
Merger
10→1
Jan 20, 2023
Merger
10→1
Jan 20, 2023
Merger
10→1
Jan 20, 2023
Merger
10→1
Date
Type
Ratio
Jan 20, 2023
Merger
10→1
Jan 20, 2023
Merger
10→1
Jan 20, 2023
Merger
10→1
Jan 20, 2023
Merger
10→1
FAQs
Who are the top five shareholders of Aptorum Group Ltd?
The top five shareholders of Aptorum Group Ltd are:
CGY Investments Ltd holds 533.58K shares, accounting for 14.00% of the total shares.
Jurchen Investment Corp holds 370.31K shares, accounting for 9.71% of the total shares.
Huen (Ian) holds 137.66K shares, accounting for 3.61% of the total shares.
Osaic Holdings, Inc. holds 5.50K shares, accounting for 0.10% of the total shares.
Citi Investment Research (US) holds 995.00 shares, accounting for 0.02% of the total shares.
CGY Investments Ltd holds 533.58K shares, accounting for 14.00% of the total shares.
Jurchen Investment Corp holds 370.31K shares, accounting for 9.71% of the total shares.
Huen (Ian) holds 137.66K shares, accounting for 3.61% of the total shares.
Osaic Holdings, Inc. holds 5.50K shares, accounting for 0.10% of the total shares.
Citi Investment Research (US) holds 995.00 shares, accounting for 0.02% of the total shares.
What are the top three shareholder types of Aptorum Group Ltd?
The top three shareholder types of Aptorum Group Ltd are:
CGY Investments Ltd
Jurchen Investment Corp
Huen (Ian)
CGY Investments Ltd
Jurchen Investment Corp
Huen (Ian)
How many institutions hold shares of Aptorum Group Ltd (APM)?
As of 2025Q4, 12 institutions hold shares of Aptorum Group Ltd, with a combined market value of approximately 5.79K, accounting for 2.02% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.38%.
What is the biggest source of revenue for Aptorum Group Ltd?
In --, the -- business generated the highest revenue for Aptorum Group Ltd, amounting to -- and accounting for --% of total revenue.
